Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-24

FDA Approved: CARBAMAZEPINE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA's original ANDA for carbamazepine (generic anticonvulsant). This marks the availability of a generic carbamazepine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

ORIG AP for CARBAMAZEPINE (CARBAMAZEPINE)